BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hart CL, Morrison DS, Batty GD, Mitchell RJ, Davey Smith G. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ. 2010;340:c1240. [PMID: 20223873 DOI: 10.1136/bmj.c1240] [Cited by in Crossref: 232] [Cited by in F6Publishing: 221] [Article Influence: 19.3] [Reference Citation Analysis]
Number Citing Articles
1 Yilmaz Y, Byrne CD, Musso G. A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD. Expert Rev Gastroenterol Hepatol 2021;15:345-52. [PMID: 33270482 DOI: 10.1080/17474124.2021.1860019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
2 Peña S, Mäkelä P, Härkänen T, Heliövaara M, Gunnar T, Männistö S, Laatikainen T, Vartiainen E, Koskinen S. Measurement error as an explanation for the alcohol harm paradox: analysis of eight cohort studies. Int J Epidemiol 2021;49:1836-46. [PMID: 32995840 DOI: 10.1093/ije/dyaa113] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Choi JH, Sohn W, Cho YK. The effect of moderate alcohol drinking in nonalcoholic fatty liver disease. Clin Mol Hepatol 2020;26:662-9. [PMID: 32971586 DOI: 10.3350/cmh.2020.0163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Ahmed MH, Husain NE, Almobarak AO. Nonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians? J Family Med Prim Care. 2015;4:45-52. [PMID: 25810989 DOI: 10.4103/2249-4863.152252] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
5 Roerecke M, Vafaei A, Hasan OSM, Chrystoja BR, Cruz M, Lee R, Neuman MG, Rehm J. Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2019;114:1574-86. [PMID: 31464740 DOI: 10.14309/ajg.0000000000000340] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 18.0] [Reference Citation Analysis]
6 Claridge LC. Rising liver death rate: food for thought. The Lancet 2011;377:2179-80. [DOI: 10.1016/s0140-6736(11)60962-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 Butler N, Quigg Z, Bates R, Sayle M, Ewart H. Gambling with Your Health: Associations Between Gambling Problem Severity and Health Risk Behaviours, Health and Wellbeing. J Gambl Stud 2020;36:527-38. [PMID: 31705379 DOI: 10.1007/s10899-019-09902-8] [Reference Citation Analysis]
8 Mehta G, Macdonald S, Cronberg A, Rosselli M, Khera-Butler T, Sumpter C, Al-Khatib S, Jain A, Maurice J, Charalambous C, Gander A, Ju C, Hakan T, Sherwood R, Nair D, Jalan R, Moore KP. Short-term abstinence from alcohol and changes in cardiovascular risk factors, liver function tests and cancer-related growth factors: a prospective observational study. BMJ Open 2018;8:e020673. [PMID: 29730627 DOI: 10.1136/bmjopen-2017-020673] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
9 Åberg F, Färkkilä M, Männistö V. Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies. Alcohol Clin Exp Res 2020;44:384-403. [DOI: 10.1111/acer.14271] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
10 Renehan AG, Zwahlen M, Egger M. Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer. 2015;15:484-498. [PMID: 26205341 DOI: 10.1038/nrc3967] [Cited by in Crossref: 298] [Cited by in F6Publishing: 270] [Article Influence: 42.6] [Reference Citation Analysis]
11 Zhou Z, Xu MJ, Cai Y, Wang W, Jiang JX, Varga ZV, Feng D, Pacher P, Kunos G, Torok NJ, Gao B. Neutrophil-Hepatic Stellate Cell Interactions Promote Fibrosis in Experimental Steatohepatitis. Cell Mol Gastroenterol Hepatol 2018;5:399-413. [PMID: 29552626 DOI: 10.1016/j.jcmgh.2018.01.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 11.5] [Reference Citation Analysis]
12 Ilyas G, Cingolani F, Zhao E, Tanaka K, Czaja MJ. Decreased Macrophage Autophagy Promotes Liver Injury and Inflammation from Alcohol. Alcohol Clin Exp Res 2019;43:1403-13. [PMID: 30964198 DOI: 10.1111/acer.14041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
13 Boyle M, Masson S, Anstee QM. The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease. Journal of Hepatology 2018;68:251-67. [DOI: 10.1016/j.jhep.2017.11.006] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 13.0] [Reference Citation Analysis]
14 Pose E, Pera G, Torán P, Gratacós-Ginès J, Avitabile E, Expósito C, Díaz A, Graupera I, Rubio AB, Ginès P, Fabrellas N, Caballeria L. Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: A population-based study. Liver Int 2021;41:1556-64. [PMID: 33595176 DOI: 10.1111/liv.14830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Im PK, Millwood IY, Kartsonaki C, Guo Y, Chen Y, Turnbull I, Yu C, Du H, Pei P, Lv J, Walters RG, Li L, Yang L, Chen Z; China Kadoorie Biobank (CKB) collaborative group. Alcohol drinking and risks of liver cancer and non-neoplastic chronic liver diseases in China: a 10-year prospective study of 0.5 million adults. BMC Med 2021;19:216. [PMID: 34530818 DOI: 10.1186/s12916-021-02079-1] [Reference Citation Analysis]
16 Persson EC, Schwartz LM, Park Y, Trabert B, Hollenbeck AR, Graubard BI, Freedman ND, McGlynn KA. Alcohol consumption, folate intake, hepatocellular carcinoma, and liver disease mortality. Cancer Epidemiol Biomarkers Prev 2013;22:415-21. [PMID: 23307533 DOI: 10.1158/1055-9965.EPI-12-1169] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
17 Buyco DG, Martin J, Jeon S, Hooks R, Lin C, Carr R. Experimental models of metabolic and alcoholic fatty liver disease. World J Gastroenterol 2021; 27(1): 1-18 [PMID: 33505147 DOI: 10.3748/wjg.v27.i1.1] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Buchanan R, Sinclair JMA. Alcohol use disorder and the liver. Addiction 2021;116:1270-8. [PMID: 32710592 DOI: 10.1111/add.15204] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Pimpin L, Cortez-Pinto H, Negro F, Corbould E, Lazarus JV, Webber L, Sheron N; EASL HEPAHEALTH Steering Committee. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. J Hepatol. 2018;69:718-735. [PMID: 29777749 DOI: 10.1016/j.jhep.2018.05.011] [Cited by in Crossref: 211] [Cited by in F6Publishing: 190] [Article Influence: 52.8] [Reference Citation Analysis]
20 Lazo M, Mitchell MC. Epidemiology and Risk Factors for Alcoholic Liver Disease. In: Chalasani N, Szabo G, editors. Alcoholic and Non-Alcoholic Fatty Liver Disease. Cham: Springer International Publishing; 2016. pp. 1-20. [DOI: 10.1007/978-3-319-20538-0_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Forrest E, Reed E. Alcohol and the liver. Medicine 2011;39:532-5. [DOI: 10.1016/j.mpmed.2011.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
22 Chang Y, Ryu S, Kim Y, Cho YK, Sung E, Kim H, Ahn J, Jung H, Yun KE, Kim S, Sung K, Sohn CI, Shin H, Wild SH, Byrne CD. Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis. Hepatology 2020;71:861-73. [DOI: 10.1002/hep.30867] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
23 Xie YD, Zhao CQ, Wang JP, Cheng CS, Zhou JY, Zhang Y, Xia H, Wei L. Alcohol consumption analysis among patients with liver disease in China. Chin Med J (Engl) 2019;132:420-30. [PMID: 30707167 DOI: 10.1097/CM9.0000000000000067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Bharti P, Mittal D, Ananthasivan R. Characterization of chronic liver disease based on ultrasound images using the variants of grey-level difference matrix. Proc Inst Mech Eng H 2018;232:884-900. [DOI: 10.1177/0954411918796531] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Mitchell T, Jeffrey GP, de Boer B, MacQuillan G, Garas G, Ching H, Hamdorf J, Adams LA. Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease. Am J Gastroenterol 2018;113:1484-93. [PMID: 29899440 DOI: 10.1038/s41395-018-0133-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
26 Israelsen M, Kim M, Suvitaival T, Madsen BS, Hansen CD, Torp N, Trost K, Thiele M, Hansen T, Legido-Quigley C, Krag A; MicrobLiver Consortium. Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication. JHEP Rep 2021;3:100325. [PMID: 34401690 DOI: 10.1016/j.jhepr.2021.100325] [Reference Citation Analysis]
27 Sadler S, Angus C, Gavens L, Gillespie D, Holmes J, Hamilton J, Brennan A, Meier P. Understanding the alcohol harm paradox: an analysis of sex- and condition-specific hospital admissions by socio-economic group for alcohol-associated conditions in England. Addiction 2017;112:808-17. [PMID: 27981670 DOI: 10.1111/add.13726] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
28 Sattar N, Forrest E, Preiss D. Non-alcoholic fatty liver disease. BMJ 2014;349:g4596. [PMID: 25239614 DOI: 10.1136/bmj.g4596] [Cited by in Crossref: 157] [Cited by in F6Publishing: 148] [Article Influence: 19.6] [Reference Citation Analysis]
29 Chang B, Xu MJ, Zhou Z, Cai Y, Li M, Wang W, Feng D, Bertola A, Wang H, Kunos G, Gao B. Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: An important role for CXCL1. Hepatology. 2015;62:1070-1085. [PMID: 26033752 DOI: 10.1002/hep.27921] [Cited by in Crossref: 94] [Cited by in F6Publishing: 89] [Article Influence: 13.4] [Reference Citation Analysis]
30 Ghosh Dastidar S, Warner JB, Warner DR, McClain CJ, Kirpich IA. Rodent Models of Alcoholic Liver Disease: Role of Binge Ethanol Administration. Biomolecules 2018;8:E3. [PMID: 29342874 DOI: 10.3390/biom8010003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 9.5] [Reference Citation Analysis]
31 Kwong EK, Puri P. Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease. Transl Gastroenterol Hepatol 2021;6:3. [PMID: 33409398 DOI: 10.21037/tgh.2020.02.18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
32 Sahlman P, Nissinen M, Puukka P, Jula A, Salomaa V, Männistö S, Lundqvist A, Valsta L, Perola M, Färkkilä M, Åberg F. Genetic and lifestyle risk factors for advanced liver disease among men and women. Journal of Gastroenterology and Hepatology 2019;35:291-8. [DOI: 10.1111/jgh.14770] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
33 Ramadori P, Cubero FJ, Liedtke C, Trautwein C, Nevzorova YA. Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame. Cancers (Basel). 2017;9. [PMID: 28946672 DOI: 10.3390/cancers9100130] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
34 Zhang G, Cao F, Shi L, Ma T, Zhang L. Contribution of high body mass index and alcohol use to liver cancer-related mortality: A study based on 195 countries or territories. Digestive and Liver Disease 2020;52:221-31. [DOI: 10.1016/j.dld.2019.10.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
35 Chiang DJ, Pritchard MT, Nagy LE. Obesity, diabetes mellitus, and liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2011;300:G697-G702. [PMID: 21350183 DOI: 10.1152/ajpgi.00426.2010] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 9.6] [Reference Citation Analysis]
36 Patra J, Buckley C, Kerr WC, Brennan A, Purshouse RC, Rehm J. Impact of body mass and alcohol consumption on all‐cause and liver mortality in 240 000 adults in the United States. Drug Alcohol Rev 2021;40:1061-70. [DOI: 10.1111/dar.13265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Avila MA, Dufour JF, Gerbes AL, Zoulim F, Bataller R, Burra P, Cortez-Pinto H, Gao B, Gilmore I, Mathurin P, Moreno C, Poznyak V, Schnabl B, Szabo G, Thiele M, Thursz MR. Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting. Gut 2020;69:764-80. [PMID: 31879281 DOI: 10.1136/gutjnl-2019-319720] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
38 Chiang DJ, McCullough AJ. The impact of obesity and metabolic syndrome on alcoholic liver disease. Clin Liver Dis. 2014;18:157-163. [PMID: 24274871 DOI: 10.1016/j.cld.2013.09.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
39 Song BJ, Akbar M, Jo I, Hardwick JP, Abdelmegeed MA. Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease. Adv Pharmacol 2015;74:303-72. [PMID: 26233911 DOI: 10.1016/bs.apha.2015.04.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
40 Decraecker M, Dutartre D, Hiriart JB, Irles-Depé M, Marraud des Grottes H, Chermak F, Foucher J, Delamarre A, de Ledinghen V. Long-term prognosis of patients with alcohol-related liver disease or non-alcoholic fatty liver disease according to metabolic syndrome or alcohol use. Liver Int 2021. [PMID: 34679242 DOI: 10.1111/liv.15081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Robertson J, Schaufelberger M, Lindgren M, Adiels M, Schiöler L, Torén K, McMurray J, Sattar N, Åberg M, Rosengren A. Higher Body Mass Index in Adolescence Predicts Cardiomyopathy Risk in Midlife. Circulation 2019;140:117-25. [PMID: 31132859 DOI: 10.1161/CIRCULATIONAHA.118.039132] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 6.3] [Reference Citation Analysis]
42 Chang Y, Ryu S, Sung KC, Cho YK, Sung E, Kim HN, Jung HS, Yun KE, Ahn J, Shin H, Wild SH, Byrne CD. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study. Gut. 2019;68:1667-1675. [PMID: 30472683 DOI: 10.1136/gutjnl-2018-317666] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
43 Wong THT, Buyken AE, Brand-Miller JC, Louie JCY. Is there a soft drink vs. alcohol seesaw? A cross-sectional analysis of dietary data in the Australian Health Survey 2011-12. Eur J Nutr 2020;59:2357-67. [PMID: 31489466 DOI: 10.1007/s00394-019-02084-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Archambeaud I, Auble H, Nahon P, Planche L, Fallot G, Faroux R, Gournay J, Samuel D, Kury S, Féray C. Risk factors for hepatocellular carcinoma in Caucasian patients with non-viral cirrhosis: the importance of prior obesity. Liver Int 2015;35:1872-6. [DOI: 10.1111/liv.12767] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
45 Mehta G, Sheron N. No safe level of alcohol consumption - Implications for global health. J Hepatol 2019;70:587-9. [PMID: 30704793 DOI: 10.1016/j.jhep.2018.12.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
46 Scott S, Elamin W, Giles EL, Hillier-Brown F, Byrnes K, Connor N, Newbury-Birch D, Ells L. Socio-Ecological Influences on Adolescent (Aged 10-17) Alcohol Use and Unhealthy Eating Behaviours: A Systematic Review and Synthesis of Qualitative Studies. Nutrients 2019;11:E1914. [PMID: 31443229 DOI: 10.3390/nu11081914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
47 Bharti P, Mittal D, Ananthasivan R. Computer-aided Characterization and Diagnosis of Diffuse Liver Diseases Based on Ultrasound Imaging: A Review. Ultrason Imaging 2017;39:33-61. [DOI: 10.1177/0161734616639875] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
48 Tsai J, Ford ES, Zhao G, Li C, Greenlund KJ, Croft JB. Co-occurrence of obesity and patterns of alcohol use associated with elevated serum hepatic enzymes in US adults. J Behav Med 2012;35:200-10. [PMID: 21626151 DOI: 10.1007/s10865-011-9353-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
49 Hadefi A, Degré D, Trépo E, Moreno C. Noninvasive diagnosis in alcohol-related liver disease. Health Sci Rep 2020;3:e146. [PMID: 32166191 DOI: 10.1002/hsr2.146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
50 Stender S, Kozlitina J, Nordestgaard BG, Tybjærg-Hansen A, Hobbs HH, Cohen JC. Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci. Nat Genet 2017;49:842-7. [PMID: 28436986 DOI: 10.1038/ng.3855] [Cited by in Crossref: 147] [Cited by in F6Publishing: 142] [Article Influence: 29.4] [Reference Citation Analysis]
51 Hosseini N, Shor J, Szabo G. Alcoholic Hepatitis: A Review. Alcohol Alcohol 2019;54:408-16. [PMID: 31219169 DOI: 10.1093/alcalc/agz036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
52 Whitfield JB, Masson S, Liangpunsakul S, Mueller S, Aithal GP, Eyer F, Gleeson D, Thompson A, Stickel F, Soyka M, Muellhaupt B, Daly AK, Cordell HJ, Foroud T, Lumeng L, Pirmohamed M, Nalpas B, Jacquet JM, Moirand R, Nahon P, Naveau S, Perney P, Haber PS, Seitz HK, Day CP, Mathurin P, Morgan TR, Seth D; GenomALC Consortium. Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers. Am J Gastroenterol 2021;116:106-15. [PMID: 32868629 DOI: 10.14309/ajg.0000000000000833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
53 Kirkegaard-Klitbo DM, Fuchs A, Stender S, Sigvardsen PE, Kühl JT, Kofoed KF, Køber L, Nordestgaard BG, Bendtsen F, Mocroft A, Lundgren J, Nielsen SD, Benfield T. Prevalence and Risk Factors of Moderate-to-Severe Hepatic Steatosis in Human Immunodeficiency Virus Infection: The Copenhagen Co-morbidity Liver Study. J Infect Dis 2020;222:1353-62. [PMID: 32417886 DOI: 10.1093/infdis/jiaa246] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
54 Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11-20. [PMID: 28930295 DOI: 10.1038/nrgastro.2017.109] [Cited by in Crossref: 1421] [Cited by in F6Publishing: 1332] [Article Influence: 284.2] [Reference Citation Analysis]
55 Katikireddi SV, Green MJ, Taylor AE, Davey Smith G, Munafò MR. Assessing causal relationships using genetic proxies for exposures: an introduction to Mendelian randomization. Addiction 2018;113:764-74. [PMID: 28921935 DOI: 10.1111/add.14038] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
56 Gruer L, Hart CL, Watt GC. After 50 years and 200 papers, what can the Midspan cohort studies tell us about our mortality? Public Health 2017;142:186-95. [PMID: 26255248 DOI: 10.1016/j.puhe.2015.06.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
57 Loomba R, Yang HI, Su J, Brenner D, Barrett-Connor E, Iloeje U, Chen CJ. Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. Am J Epidemiol. 2013;177:333-342. [PMID: 23355498 DOI: 10.1093/aje/kws252] [Cited by in Crossref: 106] [Cited by in F6Publishing: 93] [Article Influence: 11.8] [Reference Citation Analysis]
58 Cardoso AC, de Figueiredo-Mendes C, A Villela-Nogueira C. Current management of NAFLD/NASH. Liver Int 2021;41 Suppl 1:89-94. [PMID: 34155799 DOI: 10.1111/liv.14869] [Reference Citation Analysis]
59 Zhang XX, Wang LF, Jin L, Li YY, Hao SL, Shi YC, Zeng QL, Li ZW, Zhang Z, Lau GK, Wang FS. Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: Incidence and risk factors. World J Gastroenterol 2015; 21(12): 3554-3563 [PMID: 25834320 DOI: 10.3748/wjg.v21.i12.3554] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
60 Åberg F, Helenius-hietala J, Puukka P, Jula A. Binge drinking and the risk of liver events: A population-based cohort study. Liver Int 2017;37:1373-81. [DOI: 10.1111/liv.13408] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 8.4] [Reference Citation Analysis]
61 Meroni M, Longo M, Rametta R, Dongiovanni P. Genetic and Epigenetic Modifiers of Alcoholic Liver Disease. Int J Mol Sci. 2018;19:3857. [PMID: 30513996 DOI: 10.3390/ijms19123857] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
62 Tapper EB, Zhang P, Garg R, Nault T, Leary K, Krishnamurthy V, Su GL. Body composition predicts mortality and decompensation in compensated cirrhosis patients: A prospective cohort study. JHEP Rep 2020;2:100061. [PMID: 32039402 DOI: 10.1016/j.jhepr.2019.11.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
63 Helenius-Hietala J, Suominen AL, Ruokonen H, Knuuttila M, Puukka P, Jula A, Meurman JH, Åberg F. Periodontitis is associated with incident chronic liver disease-A population-based cohort study. Liver Int 2019;39:583-91. [PMID: 30300961 DOI: 10.1111/liv.13985] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
64 Cook PA, Morleo M, Billington D, Sanderson-Shortt K, Jones C, Gabbay M, Sheron N, Bellis MA, Phillips-Howard PA, Gilmore IT. Evaluation of work-based screening for early signs of alcohol-related liver disease in hazardous and harmful drinkers: the PrevAIL study. BMC Public Health 2015;15:532. [PMID: 26041363 DOI: 10.1186/s12889-015-1860-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
65 Ntandja Wandji LC, Gnemmi V, Mathurin P, Louvet A. Combined alcoholic and non-alcoholic steatohepatitis. JHEP Rep 2020;2:100101. [PMID: 32514497 DOI: 10.1016/j.jhepr.2020.100101] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
66 Persson EC, Schwartz LM, Park Y, Trabert B, Hollenbeck AR, Graubard BI, Freedman ND, McGlynn KA. Alcohol consumption, folate intake, hepatocellular carcinoma, and liver disease mortality. Cancer Epidemiol Biomarkers Prev. 2013;22:415-421. [PMID: 23307533 DOI: 10.1158/1055-9965-9965.epi-12-1169] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Carter AR, Borges MC, Benn M, Tybjærg-Hansen A, Davey Smith G, Nordestgaard BG, Lawlor DA. Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study. JAMA Netw Open 2019;2:e190305. [PMID: 30848805 DOI: 10.1001/jamanetworkopen.2019.0305] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
68 Grebely J, Talwalkar JA. Recognizing and preventing death from compensated cirrhosis in the community. Liver Int 2012;32:2-4. [PMID: 22098367 DOI: 10.1111/j.1478-3231.2011.02627.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
69 Stickel F, Datz C, Hampe J, Bataller R. Pathophysiology and Management of Alcoholic Liver Disease: Update 2016. Gut Liver. 2017;11:173-188. [PMID: 28274107 DOI: 10.5009/gnl16477] [Cited by in Crossref: 90] [Cited by in F6Publishing: 68] [Article Influence: 18.0] [Reference Citation Analysis]
70 Eslam M, Sanyal AJ, George J. Toward More Accurate Nomenclature for Fatty Liver Diseases. Gastroenterology 2019;157:590-3. [DOI: 10.1053/j.gastro.2019.05.064] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
71 Abe H, Aida Y, Seki N, Sugita T, Tomita Y, Nagano T, Itagaki M, Sutoh S, Nagatsuma K, Itoh K, Matsuura T, Aizawa Y. Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis. J Gastroenterol Hepatol 2015;30:1376-83. [PMID: 25778454 DOI: 10.1111/jgh.12948] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
72 Barbara M, Scott A, Alkhouri N. New insights into genetic predisposition and novel therapeutic targets for nonalcoholic fatty liver disease. Hepatobiliary Surg Nutr 2018;7:372-81. [PMID: 30498712 DOI: 10.21037/hbsn.2018.08.05] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
73 Spearman CW, Abdo A, Ambali A, Awuku YA, Kassianides C, Lesi OA, Ndomondo-Sigonda M, Onyekwere CA, Rwegasha J, Shewaye AB, Sonderup MW; Gastroenterology and Hepatology Association of sub-Saharan Africa (GHASSA). Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa. Lancet Gastroenterol Hepatol 2021;6:1047-56. [PMID: 34508669 DOI: 10.1016/S2468-1253(21)00296-X] [Reference Citation Analysis]
74 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol. 2018;69:154-181. [PMID: 29628280 DOI: 10.1016/j.jhep.2018.03.018] [Cited by in Crossref: 210] [Cited by in F6Publishing: 169] [Article Influence: 52.5] [Reference Citation Analysis]
75 Whitfield JB, Schwantes-An TH, Darlay R, Aithal GP, Atkinson SR, Bataller R, Botwin G, Chalasani NP, Cordell HJ, Daly AK, Day CP, Eyer F, Foroud T, Gleeson D, Goldman D, Haber PS, Jacquet JM, Liang T, Liangpunsakul S, Masson S, Mathurin P, Moirand R, McQuillin A, Moreno C, Morgan MY, Mueller S, Müllhaupt B, Nagy LE, Nahon P, Nalpas B, Naveau S, Perney P, Pirmohamed M, Seitz HK, Soyka M, Stickel F, Thompson A, Thursz MR, Trépo E, Morgan TR, Seth D; GenomALC Consortium. A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers. J Hepatol 2021:S0168-8278(21)02111-5. [PMID: 34656649 DOI: 10.1016/j.jhep.2021.10.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Alferink LJM, Erler NS, de Knegt RJ, Janssen HLA, Metselaar HJ, Darwish Murad S, Kiefte-de Jong JC. Adherence to a plant-based, high-fibre dietary pattern is related to regression of non-alcoholic fatty liver disease in an elderly population. Eur J Epidemiol 2020;35:1069-85. [PMID: 32323115 DOI: 10.1007/s10654-020-00627-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
77 Shield K, Rehm J. The importance of preventing alcohol-related liver disease in the USA. Lancet Public Health 2020;5:e298-9. [PMID: 32504580 DOI: 10.1016/S2468-2667(20)30118-3] [Reference Citation Analysis]
78 Townsend SA, Newsome PN. Non-alcoholic fatty liver disease in 2016. Br Med Bull 2016;119:143-56. [PMID: 27543499 DOI: 10.1093/bmb/ldw031] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
79 Idalsoaga F, Kulkarni AV, Mousa OY, Arrese M, Arab JP. Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities. Front Med (Lausanne) 2020;7:448. [PMID: 32974366 DOI: 10.3389/fmed.2020.00448] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
80 Glyn-Owen K, Böhning D, Parkes J, Roderick P, Buchanan R. The combined effect of alcohol and body mass index on risk of chronic liver disease: A systematic review and meta-analysis of cohort studies. Liver Int 2021;41:1216-26. [PMID: 33283434 DOI: 10.1111/liv.14754] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
81 Kerr WC, Karriker-Jaffe KJ, Ye Y. Examining alcohol's contribution to the US African-American/White cirrhosis mortality differential from 1950 to 2002. Alcohol Alcohol 2013;48:605-12. [PMID: 23558110 DOI: 10.1093/alcalc/agt031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
82 Yang Y, Chen Z, Deng L, Yu J, Wang K, Zhang X, Ji G, Li F. Pien Tze Huang ameliorates liver injury by inhibiting the PERK/eIF2α signaling pathway in alcohol and high-fat diet rats. Acta Histochemica 2018;120:578-85. [DOI: 10.1016/j.acthis.2018.06.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
83 Sung KC, Ryu S, Kim BS, Cheong ES, Park DI, Kim BI, Kwon MJ, Wild SH, Byrne CD. γ-Glutamyl Transferase Is Associated with Mortality Outcomes Independently of Fatty Liver. Clin Chem 2015;61:1173-81. [PMID: 26152752 DOI: 10.1373/clinchem.2015.240424] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
84 Manns MP, Burra P, Sargent J, Horton R, Karlsen TH. The Lancet-EASL Commission on liver diseases in Europe: overcoming unmet needs, stigma, and inequities. Lancet 2018;392:621-2. [PMID: 30060999 DOI: 10.1016/S0140-6736(18)31734-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
85 Kang SH, Lee HW, Yoo JJ, Cho Y, Kim SU, Lee TH, Jang BK, Kim SG, Ahn SB, Kim H, Jun DW, Choi JI, Song DS, Kim W, Jeong SW, Kim MY, Koh H, Jeong S, Lee JW, Cho YK; Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease. Clin Mol Hepatol 2021;27:363-401. [PMID: 34154309 DOI: 10.3350/cmh.2021.0178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
86 Rehm J, Patra J, Brennan A, Buckley C, Greenfield TK, Kerr WC, Manthey J, Purshouse RC, Rovira P, Shuper PA, Shield KD. The role of alcohol use in the aetiology and progression of liver disease: A narrative review and a quantification. Drug Alcohol Rev 2021. [PMID: 33783063 DOI: 10.1111/dar.13286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Houghton D, Hallsworth K, Thoma C, Cassidy S, Hardy T, Heaps S, Hollingsworth KG, Taylor R, Day CP, Masson S, Mcpherson S, Anstee QM, Trenell MI. Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers. Clinical Gastroenterology and Hepatology 2017;15:1596-1603.e3. [DOI: 10.1016/j.cgh.2017.05.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
88 Andreasson A, Carlsson AC, Önnerhag K, Hagström H. Waist/Hip Ratio Better Predicts Development of Severe Liver Disease Within 20 Years Than Body Mass Index: A Population-based Cohort Study. Clin Gastroenterol Hepatol 2017;15:1294-1301.e2. [PMID: 28342948 DOI: 10.1016/j.cgh.2017.02.040] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
89 Harman DJ, Ryder SD, James MW, Wilkes EA, Card TR, Aithal GP, Guha IN. Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using transient elastography. Aliment Pharmacol Ther 2018;47:504-15. [DOI: 10.1111/apt.14463] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
90 Tiniakos DG, Anstee QM, Burt AD. Fatty Liver Disease. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 308-71. [DOI: 10.1016/b978-0-7020-6697-9.00005-4] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
91 Gonzalez-Quintela A, Tomé S, Fernandez-Merino C, Rey J, Meijide L, Gude F. Synergistic effect of alcohol consumption and body mass on serum concentrations of cytokeratin-18. Alcohol Clin Exp Res. 2011;35:2202-2208. [PMID: 21682752 DOI: 10.1111/j.1530-0277.2011.01570.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
92 Strat YL, Gorwood P. Hazardous Drinking Is Associated with a Lower Risk of Coronary Heart Disease: Results from a National Representative Sample: Hazardous Drinking and Coronary Heart Disease. The American Journal on Addictions 2011;20:257-63. [DOI: 10.1111/j.1521-0391.2011.00125.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
93 Kraglund F, Deleuran T, Askgaard G, Fleming KM, Jepsen P. Decreasing Incidence of Alcohol-Related Liver Disease in Denmark: A 25-Year Nationwide Study. Clin Epidemiol 2021;13:1-11. [PMID: 33442297 DOI: 10.2147/CLEP.S287870] [Reference Citation Analysis]
94 McGlynn KA, London WT. The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 2011;15:223-43, vii-x. [PMID: 21689610 DOI: 10.1016/j.cld.2011.03.006] [Cited by in Crossref: 286] [Cited by in F6Publishing: 288] [Article Influence: 26.0] [Reference Citation Analysis]
95 Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019;16:411-428. [PMID: 31028350 DOI: 10.1038/s41575-019-0145-7] [Cited by in Crossref: 268] [Cited by in F6Publishing: 286] [Article Influence: 89.3] [Reference Citation Analysis]
96 Takahashi Y, Watabe S, Togashi-Kumagai A, Watanabe M, Dungubat E, Kusano H, Kobayashi Y, Harada N, Yamaji R, Sugimoto K, Fukusato T. Effects of low ethanol consumption on nonalcoholic steatohepatitis in mice. Alcohol 2020;87:51-61. [PMID: 32553943 DOI: 10.1016/j.alcohol.2020.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Everitt H, Hu M, Ajmo JM, Rogers CQ, Liang X, Zhang R, Yin H, Choi A, Bennett ES, You M. Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice. Am J Physiol Gastrointest Liver Physiol. 2013;304:G38-G47. [PMID: 23139221 DOI: 10.1152/ajpgi.00309.2012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
98 Renehan AG, Buchan IE. The impact of excess body weight at the hospital frontline. BMC Med 2014;12:64. [PMID: 24742301 DOI: 10.1186/1741-7015-12-64] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
99 Parker R, Kim SJ, Gao B. Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations. Nat Rev Gastroenterol Hepatol. 2018;15:50-59. [PMID: 28930290 DOI: 10.1038/nrgastro.2017.116] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 11.6] [Reference Citation Analysis]
100 Ahmed MH, Barakat S, Almobarak AO. Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? J Obes. 2012;2012:483135. [PMID: 23320150 DOI: 10.1155/2012/483135] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 4.6] [Reference Citation Analysis]
101 Massart J, Begriche K, Moreau C, Fromenty B. Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity. J Clin Transl Res 2017;3:212-32. [PMID: 28691103 DOI: 10.18053/jctres.03.2017S1.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
102 Dou X, Xia Y, Chen J, Qian Y, Li S, Zhang X, Song Z. Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease. Br J Pharmacol. 2014;171:4073-4086. [PMID: 24819676 DOI: 10.1111/bph.12765] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
103 Wakabayashi I. Increased body mass index modifies associations between alcohol intake and blood cholesterol profile. Eur J Clin Invest 2012;42:179-85. [PMID: 21770926 DOI: 10.1111/j.1365-2362.2011.02568.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
104 Addolorato G, Vassallo GA, Mirijello A, Gasbarrini A. Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows. Neurotherapeutics 2020;17:127-41. [PMID: 31713188 DOI: 10.1007/s13311-019-00802-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
105 Sloan ME, Gowin JL, Janakiraman R, Ester CD, Stoddard J, Stangl B, Ramchandani VA. High-risk social drinkers and heavy drinkers display similar rates of alcohol consumption. Addict Biol 2020;25:e12734. [PMID: 30821409 DOI: 10.1111/adb.12734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
106 Irvine L, Crombie IK, Cunningham KB, Williams B, Sniehotta FF, Norrie J, Melson AJ, Jones C, Rice P, Slane PW, Achison M, McKenzie A, Dimova ED, Allan S. Modifying Alcohol Consumption to Reduce Obesity: A Randomized Controlled Feasibility Study of a Complex Community-based Intervention for Men. Alcohol Alcohol 2017;52:677-84. [PMID: 29016701 DOI: 10.1093/alcalc/agx067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
107 Crombie IK, Cunningham KB, Irvine L, Williams B, Sniehotta FF, Norrie J, Melson A, Jones C, Briggs A, Rice PM, Achison M, McKenzie A, Dimova E, Slane PW. Modifying Alcohol Consumption to Reduce Obesity (MACRO): development and feasibility trial of a complex community-based intervention for men. Health Technol Assess 2017;21:1-150. [PMID: 28414020 DOI: 10.3310/hta21190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
108 Bhala N, Cézard G, Ward HJ, Bansal N, Bhopal R. Ethnic Variations in Liver- and Alcohol-Related Disease Hospitalisations and Mortality: The Scottish Health and Ethnicity Linkage Study. Alcohol and Alcoholism 2016;51:593-601. [DOI: 10.1093/alcalc/agw018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
109 Müller MF, Kendall TJ, Adams DJ, Zhou Y, Arends MJ. The murine hepatic sequelae of long-term ethanol consumption are sex-specific and exacerbated by Aldh1b1 loss. Experimental and Molecular Pathology 2018;105:63-70. [DOI: 10.1016/j.yexmp.2018.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
110 Wang W, Xu MJ, Cai Y, Zhou Z, Cao H, Mukhopadhyay P, Pacher P, Zheng S, Gonzalez FJ, Gao B. Inflammation is independent of steatosis in a murine model of steatohepatitis. Hepatology 2017;66:108-23. [PMID: 28220523 DOI: 10.1002/hep.29129] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
111 Anstee QM, Seth D, Day CP. Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease. Gastroenterology. 2016;150:1728-1744.e7. [PMID: 26873399 DOI: 10.1053/j.gastro.2016.01.037] [Cited by in Crossref: 121] [Cited by in F6Publishing: 116] [Article Influence: 20.2] [Reference Citation Analysis]
112 Arulraj R, Neuberger J. Liver transplantation: filling the gap between supply and demand. Clin Med (Lond) 2011;11:194-8. [PMID: 21526710 DOI: 10.7861/clinmedicine.11-2-194] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
113 Murphy K, Sahm L, Mccarthy S, Lambert S, Byrne S. Substance use in young persons in Ireland, a systematic review. Addictive Behaviors 2013;38:2392-401. [DOI: 10.1016/j.addbeh.2013.03.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
114 Benedé-Ubieto R, Estévez-Vázquez O, Guo F, Chen C, Singh Y, Nakaya HI, Gómez Del Moral M, Lamas-Paz A, Morán L, López-Alcántara N, Reissing J, Bruns T, Avila MA, Santamaría E, Mazariegos MS, Woitok MM, Haas U, Zheng K, Juárez I, Martín-Villa JM, Asensio I, Vaquero J, Peligros MI, Argemi J, Bataller R, Ampuero J, Romero Gómez M, Trautwein C, Liedtke C, Bañares R, Cubero FJ, Nevzorova YA. An Experimental DUAL Model of Advanced Liver Damage. Hepatol Commun 2021;5:1051-68. [PMID: 34141989 DOI: 10.1002/hep4.1698] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
115 Fierbinteanu-Braticevici C, Dina I, Petrisor A, Tribus L, Negreanu L, Carstoiu C. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol. 2010;16:4784-4791. [PMID: 20939106 DOI: 10.3748/wjg.v16i38.4784] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
116 Ahmed MH, Byrne CD. Non-Alcoholic Fatty Liver Disease. In: Byrne CD, Wild SH, editors. The Metabolic Syndrome. Oxford: Wiley-Blackwell; 2011. pp. 245-77. [DOI: 10.1002/9781444347319.ch15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
117 Hagström H. Alcohol, smoking and the liver disease patient. Best Practice & Research Clinical Gastroenterology 2017;31:537-43. [DOI: 10.1016/j.bpg.2017.09.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
118 Shahar E, Shahar DJ. Causal diagrams, information bias, and thought bias. Pragmat Obs Res 2010;1:33-47. [PMID: 27774007 DOI: 10.2147/POR.S13335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
119 Johnson MT, Johnson EA, Webber L, Friebel R, Reed HR, Lansley S, Wildman J. Modelling the size, cost and health impacts of universal basic income: What can be done in advance of a trial? Health Serv Outcomes Res Methodol 2021;:1-18. [PMID: 33867814 DOI: 10.1007/s10742-021-00246-8] [Reference Citation Analysis]
120 Arab JP, Roblero JP, Altamirano J, Bessone F, Chaves Araujo R, Higuera-De la Tijera F, Restrepo JC, Torre A, Urzua A, Simonetto DA, Abraldes JG, Méndez-Sánchez N, Contreras F, Lucey MR, Shah VH, Cortez-Pinto H, Bataller R. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). Ann Hepatol 2019;18:518-35. [PMID: 31053546 DOI: 10.1016/j.aohep.2019.04.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
121 Mccormack V, Boffetta P. Today's lifestyles, tomorrow's cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries. Annals of Oncology 2011;22:2349-57. [DOI: 10.1093/annonc/mdq763] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 6.3] [Reference Citation Analysis]
122 Thiele M, Rausch V, Fluhr G, Kjærgaard M, Piecha F, Mueller J, Straub BK, Lupșor-platon M, De-ledinghen V, Seitz HK, Detlefsen S, Madsen B, Krag A, Mueller S. Controlled attenuation parameter and alcoholic hepatic steatosis: Diagnostic accuracy and role of alcohol detoxification. Journal of Hepatology 2018;68:1025-32. [DOI: 10.1016/j.jhep.2017.12.029] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 11.5] [Reference Citation Analysis]
123 Armstrong MJ, Mellinger JL, Trivedi PJ. Alcohol Consumption in Patients with Non-alcoholic Fatty Liver Disease: Convenient vs. Inconvenient Truths. Am J Gastroenterol 2018;113:1437-9. [PMID: 30166633 DOI: 10.1038/s41395-018-0237-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
124 Ballo P, Betti I, Barchielli A, Castelli G, De Luca L, Gheorghiade M, Zuppiroli A. Body mass index, gender, and clinical outcome among hypertensive and diabetic patients with stage A/B heart failure: BMI, Stage A/B Heart Failure, and Outcome. Obesity 2013;21:E500-7. [DOI: 10.1002/oby.20420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
125 Scott S, Reilly J, Giles EL, Hillier-Brown F, Ells L, Kaner E, Adamson A. Socio-ecological influences on adolescent (aged 10-17) alcohol use and linked unhealthy eating behaviours: protocol for a systematic review and synthesis of qualitative studies. Syst Rev 2017;6:180. [PMID: 28865491 DOI: 10.1186/s13643-017-0574-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
126 Pais R, Rusu E, Ratziu V. The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease. Clin Liver Dis. 2014;18:165-178. [PMID: 24274872 DOI: 10.1016/j.cld.2013.09.015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
127 De Roza MA, Kai L, Kam JW, Chan YH, Kwek A, Ang TL, Hsiang JC. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis. World J Gastroenterol 2019; 25(33): 4933-4944 [PMID: 31543684 DOI: 10.3748/wjg.v25.i33.4933] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
128 Scott S, Beyer F, Parkinson K, Muir C, Graye A, Kaner E, Stead M, Power C, Fitzgerald N, Bradley J, Wrieden W, Adamson A. Non-Pharmacological Interventions to Reduce Unhealthy Eating and Risky Drinking in Young Adults Aged 18⁻25 Years: A Systematic Review and Meta-Analysis. Nutrients 2018;10:E1538. [PMID: 30340361 DOI: 10.3390/nu10101538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
129 Trembling PM, Apostolidou S, Gentry-Maharaj A, Parkes J, Ryan A, Tanwar S, Burnell M, Jacobs I, Menon U, Rosenberg WM. Risk of chronic liver disease in post-menopausal women due to body mass index, alcohol and their interaction: a prospective nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). BMC Public Health 2017;17:603. [PMID: 28659136 DOI: 10.1186/s12889-017-4518-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
130 Osna NA, Ganesan M, Seth D, Wyatt TA, Kidambi S, Kharbanda KK. Second hits exacerbate alcohol-related organ damage: an update. Alcohol Alcohol 2021;56:8-16. [PMID: 32869059 DOI: 10.1093/alcalc/agaa085] [Reference Citation Analysis]
131 Singh S, Loomba R. Editorial: obesity in chronic liver diseases - increased infections. Aliment Pharmacol Ther 2016;43:311-2. [PMID: 26741982 DOI: 10.1111/apt.13463] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
132 Hwang S, Ren T, Gao B. Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-fat diet and binge ethanol intake. Clin Mol Hepatol 2020;26:586-94. [PMID: 32937687 DOI: 10.3350/cmh.2020.0100] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
133 Innes HA, Hutchinson SJ, Barclay S, Cadzow E, Dillon JF, Fraser A, Goldberg DJ, Mills PR, McDonald SA, Morris J. Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness. Hepatology. 2013;57:451-460. [PMID: 22961861 DOI: 10.1002/hep.26051] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
134 Wang H, Mehal W, Nagy LE, Rotman Y. Immunological mechanisms and therapeutic targets of fatty liver diseases. Cell Mol Immunol 2021;18:73-91. [PMID: 33268887 DOI: 10.1038/s41423-020-00579-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
135 Rowell RJ, Anstee QM. An overview of the genetics, mechanisms and management of NAFLD and ALD. Clin Med (Lond). 2015;15 Suppl 6:s77-s82. [PMID: 26634687 DOI: 10.7861/clinmedicine.15-6-s77] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
136 Sheron N, Williams R. Alcohol drinking patterns and risk of liver disease in women. Lancet Public Health 2019;4:e6-7. [PMID: 30472033 DOI: 10.1016/S2468-2667(18)30241-X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
137 Younossi ZM, Marchesini G, Pinto-Cortez H, Petta S. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation. Transplantation. 2019;103:22-27. [PMID: 30335697 DOI: 10.1097/tp.0000000000002484] [Cited by in Crossref: 120] [Cited by in F6Publishing: 57] [Article Influence: 40.0] [Reference Citation Analysis]
138 Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 2014;23:R89-98. [PMID: 25064373 DOI: 10.1093/hmg/ddu328] [Cited by in Crossref: 926] [Cited by in F6Publishing: 730] [Article Influence: 115.8] [Reference Citation Analysis]
139 Kema VH, Khan I, Jamal R, Vishwakarma SK, Lakki Reddy C, Parwani K, Patel F, Patel D, Khan AA, Mandal P. Protective Effects of Diallyl Sulfide Against Ethanol-Induced Injury in Rat Adipose Tissue and Primary Human Adipocytes. Alcohol Clin Exp Res 2017;41:1078-92. [PMID: 28414868 DOI: 10.1111/acer.13398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
140 Mahli A, Thasler WE, Patsenker E, Müller S, Stickel F, Müller M, Seitz HK, Cederbaum AI, Hellerbrand C. Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro. Oncotarget 2015;6:41464-78. [PMID: 26497211 DOI: 10.18632/oncotarget.6203] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
141 Louvet A, Krag A. Managing excessive alcohol consumption at a population level: The earlier the better. J Hepatol 2018;68:389-90. [PMID: 29395456 DOI: 10.1016/j.jhep.2017.12.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
142 Brea Á, Pintó X, Ascaso JF, Blasco M, Díaz Á, González-santos P, Hernández-mijares A, Mantilla T, Millán J, Pedro-botet J. Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento (II). Tratamiento de la enfermedad del hígado graso no alcohólico. Clínica e Investigación en Arteriosclerosis 2017;29:185-200. [DOI: 10.1016/j.arteri.2016.06.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
143 Forrest E. Alcohol and the liver. Medicine 2015;43:581-4. [DOI: 10.1016/j.mpmed.2015.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
144 Bharti P, Mittal D, Ananthasivan R. Preliminary Study of Chronic Liver Classification on Ultrasound Images Using an Ensemble Model. Ultrason Imaging. 2018;40:357-379. [PMID: 30015593 DOI: 10.1177/0161734618787447] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
145 Parker R, Kim SJ, Im GY, Nahas J, Dhesi B, Vergis N, Sinha A, Ghezzi A, Rink MR, McCune A, Aithal GP, Newsome PN, Weston CJ, Holt A, Gao B. Obesity in acute alcoholic hepatitis increases morbidity and mortality. EBioMedicine 2019;45:511-8. [PMID: 31278069 DOI: 10.1016/j.ebiom.2019.03.046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
146 Alferink LJM, Radjabzadeh D, Erler NS, Vojinovic D, Medina-Gomez C, Uitterlinden AG, de Knegt RJ, Amin N, Ikram MA, Janssen HLA, Kiefte-de Jong JC, Metselaar HJ, van Duijn CM, Kraaij R, Darwish Murad S. Microbiomics, Metabolomics, Predicted Metagenomics, and Hepatic Steatosis in a Population-Based Study of 1,355 Adults.Hepatology. 2021;73:968-982. [PMID: 32530501 DOI: 10.1002/hep.31417] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
147 Dunn W, Zeng Z, O’Neil M, Zhao J, Whitener M, Yu-Jui Wan Y, Mitchell EK, Handler M, Weinman SA. The interaction of rs738409, obesity, and alcohol: a population-based autopsy study. Am J Gastroenterol. 2012;107:1668-1674. [PMID: 23032985 DOI: 10.1038/ajg.2012.285] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
148 Jung F, Lippmann T, Brandt A, Jin CJ, Engstler AJ, Baumann A. Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice. Eur J Nutr 2020;59:787-99. [PMID: 30879098 DOI: 10.1007/s00394-019-01945-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
149 Jarvis H, O'Keefe H, Craig D, Stow D, Hanratty B, Anstee QM. Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis. BMJ Open 2022;12:e049767. [PMID: 34983755 DOI: 10.1136/bmjopen-2021-049767] [Reference Citation Analysis]
150 Wang ZG, Dou XB, Zhou ZX, Song ZY. Adipose tissue-liver axis in alcoholic liver disease. World J Gastrointest Pathophysiol 2016; 7(1): 17-26 [PMID: 26909225 DOI: 10.4291/wjgp.v7.i1.17] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
151 Tsai J, Ford ES, Li C, Zhao G. Past and current alcohol consumption patterns and elevations in serum hepatic enzymes among US adults. Addict Behav. 2012;37:78-84. [PMID: 21975024 DOI: 10.1016/j.addbeh.2011.09.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
152 Fukuda T, Hamaguchi M, Kojima T, Mitsuhashi K, Hashimoto Y, Ohbora A, Kato T, Nakamura N, Fukui M. Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men. Eur J Gastroenterol Hepatol. 2016;28:1443-1449. [PMID: 27603300 DOI: 10.1097/meg.0000000000000736] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
153 Abrantes AM, Kunicki Z, Braun T, Miranda R Jr, Blevins CE, Brick L, Thomas G, Marsh E, Feltus S, Stein MD. Daily associations between alcohol and sweets craving and consumption in early AUD recovery: Results from an ecological momentary assessment study. J Subst Abuse Treat 2021;:108614. [PMID: 34493429 DOI: 10.1016/j.jsat.2021.108614] [Reference Citation Analysis]
154 Gopal T, Kumar N, Perriotte-Olson C, Casey CA, Donohue TM Jr, Harris EN, Talmon G, Kabanov AV, Saraswathi V. Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver. Am J Physiol Gastrointest Liver Physiol. 2020;318:G428-G438. [PMID: 31928222 DOI: 10.1152/ajpgi.00217.2019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
155 Hagström H, Stål P, Hultcrantz R, Hemmingsson T, Andreasson A. Overweight in late adolescence predicts development of severe liver disease later in life: A 39years follow-up study. Journal of Hepatology 2016;65:363-8. [DOI: 10.1016/j.jhep.2016.03.019] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
156 Standing HC, Jarvis H, Orr J, Exley C, Hudson M, Kaner E, Hanratty B. GPs' experiences and perceptions of early detection of liver disease: a qualitative study in primary care. Br J Gen Pract 2018;68:e743-9. [PMID: 30249611 DOI: 10.3399/bjgp18X699377] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
157 Li Z, Treyzon L, Chen S, Yan E, Thames G, Carpenter CL. Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial. Nutr J 2010;9:72. [PMID: 21194471 DOI: 10.1186/1475-2891-9-72] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
158 Orman ES, Odena G, Bataller R. Alcoholic liver disease: pathogenesis, management, and novel targets for therapy. J Gastroenterol Hepatol. 2013;28 Suppl 1:77-84. [PMID: 23855300 DOI: 10.1111/jgh.12030] [Cited by in Crossref: 144] [Cited by in F6Publishing: 138] [Article Influence: 18.0] [Reference Citation Analysis]
159 Mazzolini G, Sowa JP, Atorrasagasti C, Kücükoglu Ö, Syn WK, Canbay A. Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence. Cells 2020;9:E2458. [PMID: 33187255 DOI: 10.3390/cells9112458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
160 Bernardo S, Crespo R, Saraiva S, Barata R, Gonçalves S, Nogueira P, Cortez-Pinto H, Machado MV. Outcomes of excessive alcohol drinkers without baseline evidence of chronic liver disease after 15 years follow-up: Heavy burden of cancer and liver disease mortality. PLoS One 2021;16:e0252218. [PMID: 34033642 DOI: 10.1371/journal.pone.0252218] [Reference Citation Analysis]
161 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of alcoholic liver disease. Clin Mol Hepatol. 2013;19:216-254. [PMID: 24133661 DOI: 10.3350/cmh.2013.19.3.216] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
162 Akasaki M, Ploubidis GB, Dodgeon B, Bonell CP. The clustering of risk behaviours in adolescence and health consequences in middle age. J Adolesc 2019;77:188-97. [PMID: 31770671 DOI: 10.1016/j.adolescence.2019.11.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
163 Parker R, Oo YH, Adams DH. Management of patients with difficult autoimmune hepatitis. Therap Adv Gastroenterol. 2012;5:421-437. [PMID: 23152735 DOI: 10.1177/1756283X12450251] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
164 Hydes TJ, Ravi S, Loomba R, E Gray M. Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH. Clin Mol Hepatol 2020;26:383-400. [PMID: 32674529 DOI: 10.3350/cmh.2020.0067] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
165 Byrne CD, Targher G. Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. Arterioscler Thromb Vasc Biol. 2014;34:1155-1161. [PMID: 24743428 DOI: 10.1161/atvbaha.114.303034] [Cited by in Crossref: 96] [Cited by in F6Publishing: 56] [Article Influence: 12.0] [Reference Citation Analysis]
166 Afonso MB, Castro RE, Rodrigues CMP. Processes exacerbating apoptosis in non-alcoholic steatohepatitis. Clin Sci (Lond) 2019;133:2245-64. [PMID: 31742325 DOI: 10.1042/CS20190068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
167 Coppell KJ, Miller JC, Gray AR, Schultz M, Mann JI, Parnell WR. Obesity and the extent of liver damage among adult New Zealanders: findings from a national survey. Obes Sci Pract 2015;1:67-77. [PMID: 27774250 DOI: 10.1002/osp4.13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
168 Carr RM, Correnti J. Insulin resistance in clinical and experimental alcoholic liver disease. Ann N Y Acad Sci. 2015;1353:1-20. [PMID: 25998863 DOI: 10.1111/nyas.12787] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
169 Lawder R, Grant I, Storey C, Walsh D, Whyte B, Hanlon P. Epidemiology of hospitalization due to alcohol-related harm: evidence from a Scottish cohort study. Public Health 2011;125:533-9. [PMID: 21794884 DOI: 10.1016/j.puhe.2011.05.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
170 Hagström H. Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much? Curr Hepatol Rep 2017;16:152-7. [PMID: 28706775 DOI: 10.1007/s11901-017-0343-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
171 Israelsen M, Juel HB, Detlefsen S, Madsen BS, Rasmussen DN, Larsen TR, Kjærgaard M, Fernandes Jensen MJ, Stender S, Hansen T, Krag A, Thiele M; GALAXY and MicrobLiver consortiak. Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31628-1. [PMID: 33279778 DOI: 10.1016/j.cgh.2020.11.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
172 Dunn RA, Tefft NW. Has increased body weight made driving safer? Health Econ 2014;23:1374-89. [PMID: 24038409 DOI: 10.1002/hec.2991] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
173 Coe PO, O’Reilly DA, Renehan AG. Excess adiposity and gastrointestinal cancer. Br J Surg. 2014;101:1518-131; discussion 1531. [PMID: 25224741 DOI: 10.1002/bjs.9623] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
174 Hagström H, Höijer J, Andreasson A, Bottai M, Johansson K, Ludvigsson JF, Stephansson O. Body mass index in early pregnancy and future risk of severe liver disease: a population-based cohort study. Aliment Pharmacol Ther 2019;49:789-96. [PMID: 30714185 DOI: 10.1111/apt.15162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
175 Kwong EK, Liu R, Zhao D, Li X, Zhu W, Wang X, Gurley EC, Lai G, Liu J, Hylemon PB, Zhou H. The role of sphingosine kinase 2 in alcoholic liver disease. Dig Liver Dis 2019;51:1154-63. [PMID: 31003959 DOI: 10.1016/j.dld.2019.03.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
176 Foschi FG, Bedogni G, Domenicali M, Giacomoni P, Dall'Aglio AC, Dazzani F, Lanzi A, Conti F, Savini S, Saini G, Bernardi M, Andreone P, Gastaldelli A, Casadei Gardini A, Tiribelli C, Bellentani S, Stefanini GF. Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study. BMC Gastroenterol 2018;18:177. [PMID: 30486798 DOI: 10.1186/s12876-018-0906-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
177 Nabavi SF, Daglia M, Moghaddam AH, Habtemariam S, Nabavi SM. Curcumin and Liver Disease: from Chemistry to Medicine: Curcumin and liver disease…. Comprehensive Reviews in Food Science and Food Safety 2014;13:62-77. [DOI: 10.1111/1541-4337.12047] [Cited by in Crossref: 97] [Cited by in F6Publishing: 59] [Article Influence: 10.8] [Reference Citation Analysis]
178 Männistö V, Färkkilä M, Pussinen P, Jula A, Männistö S, Lundqvist A, Valsta L, Salomaa V, Perola M, Åberg F. Serum lipopolysaccharides predict advanced liver disease in the general population. JHEP Rep 2019;1:345-52. [PMID: 32039385 DOI: 10.1016/j.jhepr.2019.09.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
179 Sharma P, Arora A. Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis. Transl Gastroenterol Hepatol 2020;5:19. [PMID: 32258523 DOI: 10.21037/tgh.2019.10.02] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
180 Leggio L, Lee MR. Treatment of Alcohol Use Disorder in Patients with Alcoholic Liver Disease. Am J Med. 2017;130:124-134. [PMID: 27984008 DOI: 10.1016/j.amjmed.2016.10.004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 8.7] [Reference Citation Analysis]
181 Delacôte C, Bauvin P, Louvet A, Dautrecque F, Ntandja Wandji LC, Lassailly G, Voican C, Perlemuter G, Naveau S, Mathurin P, Deuffic-burban S. A Model to Identify Heavy Drinkers at High Risk for Liver Disease Progression. Clinical Gastroenterology and Hepatology 2020;18:2315-2323.e6. [DOI: 10.1016/j.cgh.2019.12.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
182 Tsai J, Ford ES, Zhao G, Croft JB. Multiple health behaviors and serum hepatic enzymes among US adults with obesity. Preventive Medicine 2011;53:278-83. [DOI: 10.1016/j.ypmed.2011.08.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
183 Kelly EM, Feldstein VA, Etheridge D, Hudock R, Peters MG. Sonography Predicts Liver Steatosis in Patients With Chronic Hepatitis B: Sonography Predicts Liver Steatosis in Patients With Chronic Hepatitis B. J Ultrasound Med 2017;36:925-32. [DOI: 10.7863/ultra.16.04076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
184 Rosoff DB, Charlet K, Jung J, Lee J, Muench C, Luo A, Longley M, Mauro KL, Lohoff FW. Association of High-Intensity Binge Drinking With Lipid and Liver Function Enzyme Levels. JAMA Netw Open 2019;2:e195844. [PMID: 31199452 DOI: 10.1001/jamanetworkopen.2019.5844] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
185 Stickel F, Moreno C, Hampe J, Morgan MY. The genetics of alcohol dependence and alcohol-related liver disease. J Hepatol 2017;66:195-211. [PMID: 27575312 DOI: 10.1016/j.jhep.2016.08.011] [Cited by in Crossref: 78] [Cited by in F6Publishing: 61] [Article Influence: 13.0] [Reference Citation Analysis]
186 Li F, Chen J, Liu Y, Gu Z, Jiang M, Zhang L, Chen SY, Deng Z, McClain CJ, Feng W. Deficiency of Cathelicidin Attenuates High-Fat Diet Plus Alcohol-Induced Liver Injury through FGF21/Adiponectin Regulation. Cells 2021;10:3333. [PMID: 34943840 DOI: 10.3390/cells10123333] [Reference Citation Analysis]
187 Loomba R, Lim JK, Patton H, El-Serag HB. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review. Gastroenterology 2020;158:1822-30. [PMID: 32006545 DOI: 10.1053/j.gastro.2019.12.053] [Cited by in Crossref: 49] [Cited by in F6Publishing: 60] [Article Influence: 24.5] [Reference Citation Analysis]
188 Hart CL, Davey Smith G, Gruer L, Watt GC. The combined effect of smoking tobacco and drinking alcohol on cause-specific mortality: a 30 year cohort study. BMC Public Health 2010;10:789. [PMID: 21184680 DOI: 10.1186/1471-2458-10-789] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 5.5] [Reference Citation Analysis]
189 Duly AM, Alani B, Huang EY, Yee C, Haber PS, McLennan SV, Seth D. Effect of multiple binge alcohol on diet-induced liver injury in a mouse model of obesity. Nutr Diabetes. 2015;5:e154. [PMID: 25915743 DOI: 10.1038/nutd.2015.4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
190 Poole LG, Dolin CE, Arteel GE. Organ-Organ Crosstalk and Alcoholic Liver Disease. Biomolecules 2017;7:E62. [PMID: 28812994 DOI: 10.3390/biom7030062] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
191 Åberg F, Helenius-hietala J, Puukka P, Färkkilä M, Jula A. Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population: Åberg et al. Hepatology 2018;67:2141-9. [DOI: 10.1002/hep.29631] [Cited by in Crossref: 85] [Cited by in F6Publishing: 82] [Article Influence: 21.3] [Reference Citation Analysis]
192 Brion MA, Benyamin B, Visscher PM, Smith GD. Beyond the Single SNP: Emerging Developments in Mendelian Randomization in the “Omics” Era. Curr Epidemiol Rep 2014;1:228-36. [DOI: 10.1007/s40471-014-0024-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
193 Williams R, Aithal G, Alexander GJ, Allison M, Armstrong I, Aspinall R, Baker A, Batterham R, Brown K, Burton R, Cramp ME, Day N, Dhawan A, Drummond C, Ferguson J, Foster G, Gilmore I, Greenberg J, Henn C, Jarvis H, Kelly D, Mathews M, Mccloud A, Macgilchrist A, Mckee M, Moriarty K, Morling J, Newsome P, Rice P, Roberts S, Rutter H, Samyn M, Severi K, Sheron N, Thorburn D, Verne J, Vohra J, Williams J, Yeoman A. Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK. The Lancet 2020;395:226-39. [DOI: 10.1016/s0140-6736(19)32908-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
194 Burton R, Henn C, Lavoie D, O'Connor R, Perkins C, Sweeney K, Greaves F, Ferguson B, Beynon C, Belloni A, Musto V, Marsden J, Sheron N. A rapid evidence review of the effectiveness and cost-effectiveness of alcohol control policies: an English perspective. Lancet. 2017;389:1558-1580. [PMID: 27919442 DOI: 10.1016/s0140-6736(16)32420-5] [Cited by in Crossref: 119] [Cited by in F6Publishing: 58] [Article Influence: 19.8] [Reference Citation Analysis]
195 Scott S, Parkinson K, Kaner E, Robalino S, Stead M, Power C, Fitzgerald N, Wrieden W, Adamson A. Non-pharmacological interventions designed to reduce health risks due to unhealthy eating behaviour and linked risky or excessive drinking in adults aged 18-25 years: a systematic review protocol. Syst Rev 2017;6:42. [PMID: 28253914 DOI: 10.1186/s13643-017-0434-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
196 Petroni ML, Brodosi L, Marchignoli F, Musio A, Marchesini G. Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink? Nutrients 2019;11:E3048. [PMID: 31847199 DOI: 10.3390/nu11123048] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
197 Dillon A, Galvin Z, Sultan AA, Harman D, Guha IN, Stewart S. Transient elastography can stratify patients with Child–Pugh A cirrhosis according to risk of early decompensation. European Journal of Gastroenterology & Hepatology 2018;30:1434-40. [DOI: 10.1097/meg.0000000000001224] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Williams R. Hepatology through the crystal ball. Hepatol Int 2019;13:403-6. [PMID: 31273617 DOI: 10.1007/s12072-019-09959-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
199 Harris R, Card TR, Delahooke T, Aithal GP, Guha IN. Obesity Is the Most Common Risk Factor for Chronic Liver Disease: Results From a Risk Stratification Pathway Using Transient Elastography. Am J Gastroenterol 2019;114:1744-52. [DOI: 10.14309/ajg.0000000000000357] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
200 Daniels SJ, Leeming DJ, Detlefsen S, Bruun MF, Hjuler ST, Henriksen K, Hein P, Krag A, Karsdal MA, Nielsen MJ, Brockbank S, Cruwys S. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2020;318:G410-8. [PMID: 31905026 DOI: 10.1152/ajpgi.00066.2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
201 Hsiang JC, Bai WW, Raos Z, Stableforth W, Upton A, Selvaratnam S, Gane EJ, Gerred SJ. Epidemiology, disease burden and outcomes of cirrhosis in a large secondary care hospital in South Auckland, New Zealand: Cirrhosis outcomes in New Zealand. Intern Med J 2015;45:160-9. [DOI: 10.1111/imj.12624] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
202 Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018;113:175-194. [PMID: 29336434 DOI: 10.1038/ajg.2017.469] [Cited by in Crossref: 205] [Cited by in F6Publishing: 176] [Article Influence: 51.3] [Reference Citation Analysis]
203 Koo S, Sharp L, Hull M, Rushton S, Neilson LJ, McPherson S, Rees CJ; OSCAR study team. Uncovering undiagnosed liver disease: prevalence and opportunity for intervention in a population attending colonoscopy. BMJ Open Gastroenterol 2021;8:e000638. [PMID: 34011624 DOI: 10.1136/bmjgast-2021-000638] [Reference Citation Analysis]
204 Batty GD, Gale CR, Kivimäki M, Bell S. Assessment of Relative Utility of Underlying vs Contributory Causes of Death. JAMA Netw Open 2019;2:e198024. [PMID: 31365105 DOI: 10.1001/jamanetworkopen.2019.8024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
205 Karlsen TH, Sheron N, Zelber-Sagi S, Carrieri P, Dusheiko G, Bugianesi E, Pryke R, Hutchinson SJ, Sangro B, Martin NK, Cecchini M, Dirac MA, Belloni A, Serra-Burriel M, Ponsioen CY, Sheena B, Lerouge A, Devaux M, Scott N, Hellard M, Verkade HJ, Sturm E, Marchesini G, Yki-Järvinen H, Byrne CD, Targher G, Tur-Sinai A, Barrett D, Ninburg M, Reic T, Taylor A, Rhodes T, Treloar C, Petersen C, Schramm C, Flisiak R, Simonova MY, Pares A, Johnson P, Cucchetti A, Graupera I, Lionis C, Pose E, Fabrellas N, Ma AT, Mendive JM, Mazzaferro V, Rutter H, Cortez-Pinto H, Kelly D, Burton R, Lazarus JV, Ginès P, Buti M, Newsome PN, Burra P, Manns MP. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet 2022;399:61-116. [PMID: 34863359 DOI: 10.1016/S0140-6736(21)01701-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Bellis MA, Hughes K, Nicholls J, Sheron N, Gilmore I, Jones L. The alcohol harm paradox: using a national survey to explore how alcohol may disproportionately impact health in deprived individuals. BMC Public Health 2016;16:111. [PMID: 26888538 DOI: 10.1186/s12889-016-2766-x] [Cited by in Crossref: 101] [Cited by in F6Publishing: 82] [Article Influence: 16.8] [Reference Citation Analysis]
207 Singal AK, Mathurin P. Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review. JAMA 2021;326:165-76. [PMID: 34255003 DOI: 10.1001/jama.2021.7683] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
208 Singh A, Amin H, Garg R, Gupta M, Lopez R, Alkhouri N, Mccullough A. Increased Prevalence of Obesity and Metabolic Syndrome in Patients with Alcoholic Fatty Liver Disease. Dig Dis Sci 2020;65:3341-9. [DOI: 10.1007/s10620-020-06056-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
209 Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151-171. [PMID: 30266282 DOI: 10.1016/j.jhep.2018.09.014] [Cited by in Crossref: 615] [Cited by in F6Publishing: 559] [Article Influence: 153.8] [Reference Citation Analysis]
210 Bellis MA, Hardcastle K, Ford K, Hughes K, Ashton K, Quigg Z, Butler N. Does continuous trusted adult support in childhood impart life-course resilience against adverse childhood experiences - a retrospective study on adult health-harming behaviours and mental well-being. BMC Psychiatry 2017;17:110. [PMID: 28335746 DOI: 10.1186/s12888-017-1260-z] [Cited by in Crossref: 55] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
211 Liangpunsakul S, Gao B. Alcohol and fat promote steatohepatitis: a critical role for fat-specific protein 27/CIDEC. J Investig Med 2016;64:1078-81. [PMID: 27342423 DOI: 10.1136/jim-2016-000204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
212 Patel M, Shariff MI, Ladep NG, Thillainayagam AV, Thomas HC, Khan SA, Taylor-Robinson SD. Hepatocellular carcinoma: diagnostics and screening. J Eval Clin Pract 2012;18:335-42. [PMID: 21114800 DOI: 10.1111/j.1365-2753.2010.01599.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
213 Liangpunsakul S, Haber P, McCaughan GW. Alcoholic Liver Disease in Asia, Europe, and North America. Gastroenterology. 2016;150:1786-1797. [PMID: 26924091 DOI: 10.1053/j.gastro.2016.02.043] [Cited by in Crossref: 74] [Cited by in F6Publishing: 74] [Article Influence: 12.3] [Reference Citation Analysis]
214 Bucher S, Le Guillou D, Allard J, Pinon G, Begriche K, Tête A, Sergent O, Lagadic-Gossmann D, Fromenty B. Possible Involvement of Mitochondrial Dysfunction and Oxidative Stress in a Cellular Model of NAFLD Progression Induced by Benzo[a]pyrene/Ethanol CoExposure. Oxid Med Cell Longev 2018;2018:4396403. [PMID: 30147834 DOI: 10.1155/2018/4396403] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
215 Peeraphatdit TB, Ahn JC, Choi DH, Allen AM, Simonetto DA, Kamath PS, Shah VH. A Cohort Study Examining the Interaction of Alcohol Consumption and Obesity in Hepatic Steatosis and Mortality. Mayo Clin Proc 2020;95:2612-20. [PMID: 33276835 DOI: 10.1016/j.mayocp.2020.04.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
216 Fierbinteanu-Braticevici C, Dina I, Petrisor A, Tribus L, Negreanu L, Carstoiu C. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol 2010; 16(38): 4784-4791 [PMID: 20939106 DOI: 10.3748/wjg.v16.i38.4784] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
217 Chen CP, Haas-kogan D. Neoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnostics. Expert Review of Molecular Diagnostics 2014;10:883-95. [DOI: 10.1586/erm.10.76] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
218 Warner DR, Warner JB, Hardesty JE, Song YL, King TN, Kang JX, Chen CY, Xie S, Yuan F, Prodhan MAI, Ma X, Zhang X, Rouchka EC, Maddipati KR, Whitlock J, Li EC, Wang GP, McClain CJ, Kirpich IA. Decreased ω-6:ω-3 PUFA ratio attenuates ethanol-induced alterations in intestinal homeostasis, microbiota, and liver injury. J Lipid Res 2019;60:2034-49. [PMID: 31586017 DOI: 10.1194/jlr.RA119000200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
219 Mathers JC, Strathdee G, Relton CL. Induction of epigenetic alterations by dietary and other environmental factors. Adv Genet 2010;71:3-39. [PMID: 20933124 DOI: 10.1016/B978-0-12-380864-6.00001-8] [Cited by in Crossref: 178] [Cited by in F6Publishing: 90] [Article Influence: 14.8] [Reference Citation Analysis]
220 Peña S, Mäkelä P, Laatikainen T, Härkänen T, Männistö S, Heliövaara M, Koskinen S. Joint effects of alcohol use, smoking and body mass index as an explanation for the alcohol harm paradox: causal mediation analysis of eight cohort studies. Addiction 2021;116:2220-30. [PMID: 33404149 DOI: 10.1111/add.15395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
221 Yi SW, Hong JS, Yi JJ, Ohrr H. Impact of alcohol consumption and body mass index on mortality from nonneoplastic liver diseases, upper aerodigestive tract cancers, and alcohol use disorders in Korean older middle-aged men: Prospective cohort study. Medicine (Baltimore) 2016;95:e4876. [PMID: 27684819 DOI: 10.1097/MD.0000000000004876] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
222 Naran NH, Haagensen M, Crowther NJ. Steatosis in South African women: How much and why? PLoS One 2018;13:e0191388. [PMID: 29351564 DOI: 10.1371/journal.pone.0191388] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
223 Unalp-Arida A, Ruhl CE. Transient Elastography-Assessed Hepatic Steatosis and Fibrosis Are Associated With Body Composition in the United States. Clin Gastroenterol Hepatol. 2021;. [PMID: 33549867 DOI: 10.1016/j.cgh.2021.02.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
224 Dalekos GN, Gatselis NK, Zachou K, Koukoulis GK. NAFLD and autoimmune hepatitis: Do not judge a book by its cover. Eur J Intern Med 2020;75:1-9. [PMID: 32051092 DOI: 10.1016/j.ejim.2020.02.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
225 Gellert-Kristensen H, Nordestgaard BG, Tybjaerg-Hansen A, Stender S. High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase-Lowering Effect of a HSD17B13 Variant. Hepatology. 2020;71:56-66. [PMID: 31155741 DOI: 10.1002/hep.30799] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
226 Francque SM, Marchesini G, Kautz A, Walmsley M, Dorner R, Lazarus JV, Zelber-Sagi S, Hallsworth K, Busetto L, Frühbeck G, Dicker D, Woodward E, Korenjak M, Willemse J, Koek GH, Vinker S, Ungan M, Mendive JM, Lionis C. Non-alcoholic fatty liver disease: A patient guideline. JHEP Rep 2021;3:100322. [PMID: 34693236 DOI: 10.1016/j.jhepr.2021.100322] [Reference Citation Analysis]
227 Qin X, Lin L, Mo Z, Lv H, Gao Y, Tan A, Yang X, Li S, Zhao J. Reference intervals for serum alpha-fetoprotein and carcinoembryonic antigen in Chinese Han ethnic males from the Fangchenggang Area Male Health and Examination Survey. Int J Biol Markers 2011;26:65-71. [PMID: 21337313 DOI: 10.5301/jbm.2011.6364] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]